Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects

Annals of Nutrition and Metabolism

Volumn 51, Issue 2, 2007, Pages 134-138

  De Luis, D A ^a   Gonzalez Sagrado, M ^a   Conde, R ^a   Aller, R ^a   Izaola, O ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Cardiovascular risk factors; Glucagon like peptide 1; Hypocaloric diet; Obesity; Weight

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AEROBIC EXERCISE; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); FEMALE; HUMAN; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTPATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

ADIPOSE TISSUE; ANTHROPOMETRY; BLOOD GLUCOSE; BODY MASS INDEX; DIET, REDUCING; EXERCISE; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; LIPID METABOLISM; MALE; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 34250855012     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000103273     Document Type: Article

References (24)

1. Meier U, Gressner AM: Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin and resistin. Clin Chem 2004;50:1511-1525.
2. Westerterp-Plantenga MS: Analysis of energy density of food in relation to energy intake regulation in human subjects. Br J Nutr 2001;85:351-361.
3. Blundell JE, Lawton CL, Hill AJ: Mechanisms of appetite control and their abnormalities in obese patients. Horm Res 1993;39:72-76.
4. Blundell JE, Näslund E: Glucagon-like peptide-1, satiety and appetite control. Br J Nutr 1999;81:259-160.
5. Holst JJ: Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology 1994;107:1848-1855
6. Näslund E, Barkeling B, King N, et al: Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord 1999;23:304-311.
7. Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R: Attenuated GLP-1 secretion in obesity: cause or consequence. Gut 1996:38:916-919.
8. Verdich C, Toubro S, Buemann B, Lysgard Madsen J, Juul Holst J, Astrup A: The role of postprandial releases of insulin and incretin hormones in meal-induced satiety: effect of obesity and weight reduction. Int J Obes Relat Metab Disord 2001;25:1206-1214.
9. Cigaina V, Hirschberg Al: Gastric pacing for morbid obesity: plasma levels of gastrointestinal peptides and leptin. Obes Res 2003;111:1456-1462.
10. Damci T, Yalin S, Balci H: Orlistat augments postprandial increases in GLP-1 in obese type 2 diabetic patients. Diabetes Care 2004;27:1077-1080.
11. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF: Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-414.
12. Pichard C, Slosman D, Hirschel B, Kyle U: Bioimpedance analysis in AIDS patients: an improved method for nutritional follow-up. Clin Res 1993;41:53.
13. Adam TCM, Jocken J, Westerterp-Plantenga MS: Decreased glucagon-like peptide 1 release after weight loss in overweight/obese subjects. Obes Res 2005;13:710-715.
14. Näslund E, Gryback P, Hellström PM: Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord 1997;21:387-392.
15. Westerterp-Plantenga MS, Lejeune MP, Nijs I, van Ooijen M, Kovacs EM: High protein intake sustains weight maintenance after body weight loss in humans. Int J Obes Relat Metab Disord 2004;28:57-61.
16. Ranganath L, Norris F, Morgan L, Wright J, Marks V: The effect of circulating non-esterified fatty acids on the enteroinsular axis. Eur J Clin Invest 1999;29:27-32.
17. Rissanen P, Fransila-Kallunki A, Rissanen A: Cardiac parasympathetic activity is increased by weight loss in healthy obese women. Obes Res 2001;9:637-643.
18. Goldstone AP, Morgan I, Mercer JG: Effect of leptin on hypothalamic GLP-1 peptide and brain stem pre-proglucagon mRNA. Biochem Biophys Res Commun 2000;269:331-335.
19. Valverde I, Puente J, Martin-Duce A, Molina L, Lozano O, Sancho V, Malaisse WJ, Villanueva-Penacarrillo ML: Changes in glucagon-like peptide (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects. Obes Surg 2005;15:387-397.
20. Meier JJ, Gallwitz B, Schmidt WE, Nauck MA: Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol 2002;440:269-279.
21. Knauf C, Cani PD, Perrin C, Iglesias MA, Maury JF, Bernard E, Benhamed F, Gremeaux T, Drucker DJ, et al: Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 2005;115:3554-3563.
22. Elliott RM, Morgan LM, Tredger JA, Deacon S, Wright J, Marks V: Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. J Endocrinol 1993;138:159-166.
23. Choi YH, Anderson GH: An interaction between hypothalamic glucagon-like peptide-1 and macronutrient composition determines food intake in rats. J Nutr 2001;131:1819-1825.
24. Mannucci E, Tesi F, Bardini G, Ognibene A, Petracca MG, Ciani S, Pezzatini A, Brogi M, et al: Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without type 2 diabetes. Diabetes Nutr Metab 2004;17:336-342.